| Attribute |
Value |
| 52 Week Change |
-0.6240296 |
| Address1 |
The Sharp Building |
| Address2 |
Hogan Place |
| All Time High |
215.73 |
| All Time Low |
5.0 |
| Ask |
10.33 |
| Ask Size |
800 |
| Audit Risk |
4 |
| Average Daily Volume10 Day |
3,517,830 |
| Average Daily Volume3 Month |
3,196,101 |
| Average Volume |
3,196,101 |
| Average Volume10Days |
3,517,830 |
| Beta |
0.521 |
| Bid |
10.17 |
| Bid Size |
100 |
| Board Risk |
3 |
| Book Value |
18.094 |
| City |
Dublin |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
3 |
| Country |
Ireland |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
10.13 |
| Current Ratio |
2.719 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
10.2 |
| Day Low |
9.9 |
| Debt To Equity |
153.222 |
| Display Name |
Perrigo Company |
| Dividend Date |
1,781,568,000 |
| Dividend Rate |
1.16 |
| Dividend Yield |
11.35 |
| Earnings Call Timestamp End |
1,778,070,600 |
| Earnings Call Timestamp Start |
1,778,070,600 |
| Earnings Timestamp |
1,778,070,600 |
| Earnings Timestamp End |
1,785,501,000 |
| Earnings Timestamp Start |
1,785,501,000 |
| Ebitda |
637,299,968 |
| Ebitda Margins |
0.15252 |
| Enterprise To Ebitda |
7.655 |
| Enterprise To Revenue |
1.168 |
| Enterprise Value |
4,878,700,032 |
| Eps Current Year |
2.108 |
| Eps Forward |
2.362 |
| Eps Trailing Twelve Months |
-12.87 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,780,012,800 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
10.8232 |
| Fifty Day Average Change |
-0.6932001 |
| Fifty Day Average Change Percent |
-0.06404761 |
| Fifty Two Week Change Percent |
-62.402958 |
| Fifty Two Week High |
28.44 |
| Fifty Two Week High Change |
-18.310001 |
| Fifty Two Week High Change Percent |
-0.6438116 |
| Fifty Two Week Low |
9.23 |
| Fifty Two Week Low Change |
0.9000006 |
| Fifty Two Week Low Change Percent |
0.09750819 |
| Fifty Two Week Range |
9.23 - 28.44 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
692,980,200,000 |
| Five Year Avg Dividend Yield |
4.04 |
| Float Shares |
137,638,572 |
| Forward Eps |
2.362 |
| Forward P E |
4.2887383 |
| Free Cashflow |
108,425,000 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
8,100 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.34168997 |
| Gross Profits |
1,427,699,968 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00398 |
| Held Percent Institutions |
1.16713 |
| Implied Shares Outstanding |
138,367,770 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Ir Website |
http://www.perrigo.com/investors/investor_landing.aspx |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,780,012,800 |
| Last Dividend Value |
0.29 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
746,323,200 |
| Last Split Factor |
2:1 |
| Long Business Summary |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. |
| Long Name |
Perrigo Company plc |
| Market |
us_market |
| Market Cap |
1,401,665,536 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_319092 |
| Most Recent Quarter |
1,774,656,000 |
| Net Income To Common |
-1,792,300,032 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
1,407,200,220 |
| Number Of Analyst Opinions |
4 |
| Open |
10.27 |
| Operating Cashflow |
189,400,000 |
| Operating Margins |
0.03467 |
| Overall Risk |
1 |
| Payout Ratio |
109.5 |
| Peg Ratio |
1.14 |
| Phone |
353 1 709 4000 |
| Previous Close |
10.183 |
| Price Eps Current Year |
4.805503 |
| Price Hint |
2 |
| Price To Book |
0.5598541 |
| Price To Sales Trailing12 Months |
0.3354551 |
| Profit Margins |
-0.435 |
| Quick Ratio |
1.093 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.052999496 |
| Regular Market Change Percent |
-0.5204704 |
| Regular Market Day High |
10.2 |
| Regular Market Day Low |
9.9 |
| Regular Market Day Range |
9.9 - 10.2 |
| Regular Market Open |
10.27 |
| Regular Market Previous Close |
10.183 |
| Regular Market Price |
10.13 |
| Regular Market Time |
1,784,036,681 |
| Regular Market Volume |
76,270 |
| Return On Assets |
0.02088 |
| Return On Equity |
-0.52232 |
| Revenue Growth |
-0.072 |
| Revenue Per Share |
30.115 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
1 |
| Shares Outstanding |
138,367,770 |
| Shares Percent Shares Out |
0.1776 |
| Shares Short |
24,575,592 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
15,071,752 |
| Short Name |
Perrigo Company plc |
| Short Percent Of Float |
0.2728 |
| Short Ratio |
5.61 |
| Source Interval |
15 |
| Symbol |
PRGO |
| Target High Price |
20.0 |
| Target Low Price |
14.0 |
| Target Mean Price |
16.5 |
| Target Median Price |
16.0 |
| Total Cash |
357,200,000 |
| Total Cash Per Share |
2.582 |
| Total Debt |
3,828,699,904 |
| Total Revenue |
4,178,400,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
1.16 |
| Trailing Annual Dividend Yield |
0.11391535 |
| Trailing Eps |
-12.87 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
13.6585 |
| Two Hundred Day Average Change |
-3.5284996 |
| Two Hundred Day Average Change Percent |
-0.2583373 |
| Type Disp |
Equity |
| Volume |
76,270 |
| Website |
https://www.perrigo.com |
| Zip |
D02 TY74 |